Marks & Spencer Group PLC
01 March 2004
Issued: 1 March 2004
Marks & Spencer Announces its Intention to Inject £400m into the UK Defined
Benefit Pension Scheme
Marks & Spencer today announces that the actuarial valuation of the Marks &
Spencer UK Defined Benefit Pension Scheme at 31 March 2003 has been completed.
The actuarial valuation revealed a shortfall of £585m between the market value
of the assets of the UK Scheme (£2,612m) and the assessment of the liabilities
(£3,197m). This represents a funding level of 82%.
As a result of this valuation Marks & Spencer intends to make a capital
injection of £400 million into the Scheme by the end of March 2004, increasing
the funding level to 94%.
The injection will be funded, subject to market conditions, through a public
bond issue. The issue will be made under the Group's medium term note programme.
In addition, Marks & Spencer announces that it will be adopting accounting
standard FRS17 (Retirement Benefits) for the year ending 3 April 2004. The
profit and loss account pre tax charge under FRS17 for the UK Scheme for this
financial year is estimated to be £134m, (last financial year £136m, as reported
under SSAP24).
As a consequence of adopting FRS17, the previously reported FRS17 deficit of
£1.2bn (£0.9bn net of tax) at 29 March 2003 will now be reflected on the Group's
balance sheet by means of a prior year adjustment. At the end of January 2004,
the deficit had decreased to approximately £1bn before tax (£0.7bn net of tax).
Alison Reed, Group Finance Director, of Marks & Spencer, said:
'Marks & Spencer is committed to ensuring the Defined Benefit Pension Scheme is
adequately funded. By taking this action we are providing reassurance to the
Scheme members.'
'We believe that this is an opportune time to raise the funds, taking into
account current interest rates and demand in the corporate bond markets.'
Please see attached appendix for detailed analysis on the impact of the cash
injection and the adoption of FRS17.
For further information contact:
Investor Relations - Tony Quinlan 020 7268 4195 / Damian Evans 020 7268 1563
Press enquiries - 020 7268 1919, Nick Claydon / Catherine Bertwistle
Appendix
All figures reported below are in respect of the UK defined benefit scheme only.
The Group does operate other schemes but these are not material in relation to
the UK scheme or the Group as a whole.
Impact of adopting FRS17
Adopting FRS17 this year will result in a restatement of the comparative results
for the year ended 29 March 2003 as follows:-
UK Defined Benefit Pension Year ended 29 March 2003
Scheme ---------------------------------
As reported under As restated under
SSAP24 FRS17
£m £m
----------------- -----------------
Operating cost 136 122
Interest credit - (27)
----------------- ----------------- -----------------
Net cost before tax 136 95
Taxation (41) (29)
----------------- ----------------- -----------------
Net cost after tax 95 66
================= ================= =================
The reduction in the net cost after tax from £95m to £66m results in an increase
of 1.3p per share to the previously reported earnings per share of 20.7p per
share.
For the year ending 3 April 2004, the estimated charge under FRS17 to be
included in our reported results, together with the comparable SSAP24 charge,
are as follows:-
UK Defined Benefit Pension Year ending 3 April 2004
Scheme ---------------------------------
SSAP24 FRS17
£m £m
----------------- -----------------
Operating cost 177 120
Interest cost - 14
----------------- ----------------- -----------------
Net cost before tax 177 134
Taxation (53) (40)
----------------- ----------------- -----------------
Net cost after tax 124 94
================= ================= =================
Adopting FRS 17 in the current year results in an estimated reduction in the net
cost after tax of £30m, an increase in earnings per share of approximately 1.3p
per share.
FRS17 assumptions
The FRS17 assumptions are determined at the beginning of each financial year.
The main assumptions used in arriving at the pension charge under FRS17 for the
year ended 29 March 2003 and the year ending 3 April 2004 are as follows:-
FRS17 Assumptions
Year ended 29 March Year ending 3 April
2003 2004
% %
Inflation 2.5 2.5
Pension increases 2.5 2.5
Salary increases 4.0 3.5
Expected return on
assets 7.3 7.3
Discount rate 5.9 5.5
Impact for 2004/05
The FRS17 pension cost charge to EBIT for 2004/05 is estimated to be broadly
similar to 2003/04.
Interest under FRS17 is expected to be a credit, compared to the charge in 2003/
04 of £14m, driven by the injection of the £400m into the pension fund and the
influence of the equity and debt markets on the pension scheme assets and
liabilities.
The Group will incur an interest charge relating to the £400m Public Bond Issue.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.